News
Romanian Robotic & Metabolic Surgery Days 2026
Dear Colleagues, It is our great pleasure to invite you to the Romanian Robotic & Metabolic Surgery Days 2026, held under the theme “Bringing Better Care to All.” It became a tradition for the two professional associations, RAES and RSMS to organize successful...
Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery
Date: 03 Jul 2026 Munich, Germany – A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers...
ESC Congress 2026: Transforming innovative ideas into clinical reality
Key takeaways The world's leading cardiology experts will convene in Munich for ESC Congress 2026. The event takes place from 28 to 31 August, with the press programme beginning on 27 August. This year’s spotlight on artificial intelligence will explore the potential...
Common food preservatives linked to high blood pressure and heart disease
Key takeaways The study of 112,395 people includes a detailed analysis of diet and food ingredients. Researchers found eight preservative food additives linked to high blood pressure or cardiovascular disease. The highest risks were in people who ate the most...
Experts call for women’s heart centres to tackle inequality in diagnosis & care
Key takeaways: Cardiovascular disease is the leading cause of death in women. Women are more likely to have undiagnosed and untreated cardiovascular disease. Dedicated women's heart centres are needed to improve diagnosis, treatment and care. Sophia Antipolis,...
ESMO Breast Cancer 2026 – Precision Oncology, Molecular Monitoring and the Evolving Paradigm of Survivorship Care
The scientific programme of ESMO Breast Cancer 2026 highlighted the accelerating integration of precision oncology into breast cancer prevention, disease monitoring, and survivorship care. Across sessions dedicated to early detection, translational research, and early...
National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors A study presented at the ESMO Breast Cancer 2026 congress
Date: 07 May 2026 BERLIN, Germany – Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are...
Opening Ceremony of ESMO Breast Cancer 2026 Sets the Tone for Innovation and Global Collaboration
The ESMO Breast Cancer 2026 officially commenced on Wednesday, May 6, with a distinguished opening ceremony and award lecture that underscored the rapid pace of scientific advancement and the critical role of international collaboration in improving breast cancer...
Improving cardiovascular risk prediction in Latin America and the Caribbean: SCORE2-LAC
Key takeaways Cardiovascular disease risk prediction models are used to identify people who benefit most from preventive action. The Systematic COronary Risk Evaluation 2 (SCORE2) risk prediction system implemented in ESC Guidelines is based on data from European...
New data on effective cardiac resynchronisation in patients with heart failure
14 April 2026: Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronisation, according to a Late-Breaking Science presentation at EHRA 2026,1 the annual congress of the European Heart Rhythm Association (EHRA), a...
